Aurobindo Pharma Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹7,514.30Cr |
Net Profits | ₹936.29Cr |
Net Profit Margins | 12.46% |
Highlights
Revenue:
Aurobindo Pharma Ltd’s revenue jumped 15.61% since last year same period to ₹7,514.30Cr in the Q3 2023-2024. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 1.44% jump in its revenue since last 3-months.
Net Profits:
Aurobindo Pharma Ltd’s net profit jumped 90.59% since last year same period to ₹936.29Cr in the Q3 2023-2024. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 23.65% jump in its net profits since last 3-months.
Net Profit Margins:
Aurobindo Pharma Ltd’s net profit margin jumped 64.86% since last year same period to 12.46% in the Q3 2023-2024. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 21.89% jump in its net profit margins since last 3-months.
